Alain Beck
9Patents
4h-index
10Co-inventors
50Inventor score
Filing activity: Mar 15, 2000 → Jan 18, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7241444B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 54 | Expired |
| US7309494B2 | Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7553485B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 9 | Expired |
| US7914784B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US8101180B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US7524627B2 | Method of generating and/or increasing an immune response against RSV | Emerging Cross-Sectional Technologies | 1 | Active |
| US8168410B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8808999B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7033591B1 | Immunostimulant bacterial membrane fractions in cancer treatment | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.